Liquidia (NASDAQ:LQDA) Insider Sells $270,611.64 in Stock

Liquidia Corporation (NASDAQ:LQDA) insider Sanjeev Khindri sold 4,134 shares of the stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $65.46, for a total transaction of $270,611.64. Following the completion of the transaction, the insider directly owned 67,132 shares in the company, valued at approximately $4,394,460.72. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Liquidia Stock Performance

Liquidia stock traded up $1.24 during trading hours on Wednesday, hitting $65.25. The company had a trading volume of 2,327,936 shares, compared to its average volume of 1,722,392. The firm has a market cap of $5.80 billion, a PE ratio of 466.10 and a beta of 0.58. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. Liquidia Corporation has a one year low of $11.85 and a one year high of $66.78. The firm has a 50-day moving average of $47.90 and a 200 day moving average of $40.11.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.11. The firm had revenue of $132.87 million for the quarter, compared to analysts’ expectations of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. Liquidia’s quarterly revenue was up 4187.1% on a year-over-year basis. On average, sell-side analysts expect that Liquidia Corporation will post 2.97 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on LQDA shares. Jefferies Financial Group reaffirmed a “buy” rating and set a $60.00 target price on shares of Liquidia in a report on Monday, May 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Wall Street Zen raised shares of Liquidia from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 16th. BTIG Research raised their target price on shares of Liquidia from $50.00 to $59.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, HC Wainwright raised their target price on shares of Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, June 5th. Three equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $55.63.

Institutional Trading of Liquidia

Several large investors have recently made changes to their positions in the company. Farallon Capital Management LLC boosted its position in shares of Liquidia by 1.1% during the 4th quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock worth $298,547,000 after acquiring an additional 90,400 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Liquidia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock worth $138,439,000 after acquiring an additional 52,671 shares in the last quarter. Opaleye Management Inc. boosted its position in shares of Liquidia by 9.5% during the 2nd quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock worth $30,838,000 after acquiring an additional 215,000 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Liquidia by 18.7% during the 1st quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after acquiring an additional 360,372 shares in the last quarter. Finally, Caprock Group LLC boosted its position in shares of Liquidia by 9.3% during the 4th quarter. Caprock Group LLC now owns 1,783,921 shares of the company’s stock worth $61,527,000 after acquiring an additional 151,832 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).